{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:52:51Z","timestamp":1777438371291,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81373617"],"award-info":[{"award-number":["81373617"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81072793"],"award-info":[{"award-number":["81072793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30772800"],"award-info":[{"award-number":["30772800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Committee of Science and Technology Research Projects","award":["15401930400"],"award-info":[{"award-number":["15401930400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00011-017-1100-0","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T07:34:44Z","timestamp":1510299284000},"page":"117-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Astragaloside IV attenuates orbital inflammation in Graves\u2019 orbitopathy through suppression of autophagy"],"prefix":"10.1007","volume":"67","author":[{"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"1100_CR1","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","volume":"314","author":"HB Burch","year":"2015","unstructured":"Burch HB, Cooper DS. Management of graves disease: a review. JAMA. 2015;314:2544\u201354.","journal-title":"JAMA"},{"key":"1100_CR2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362:726\u201338.","journal-title":"N Engl J Med"},{"key":"1100_CR3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF03346614","volume":"33","author":"TJ Smith","year":"2010","unstructured":"Smith TJ. Pathogenesis of Graves\u2019 orbitopathy: a 2010 update. J Endocrinol Invest. 2010;33:414\u201321.","journal-title":"J Endocrinol Invest"},{"key":"1100_CR4","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/jc.2009-0376","volume":"94","author":"H Stiebel-Kalish","year":"2009","unstructured":"Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M, Ezrachi D, Shimon I, Leibovici L. Treatment modalities for Graves\u2019 ophthalmopathy: systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94:2708\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"1100_CR5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(16)30046-8","volume":"5","author":"WM Wiersinga","year":"2017","unstructured":"Wiersinga WM. Advances in treatment of active, moderate-to-severe Graves\u2019 ophthalmopathy. Lancet Diabetes Endocrinol. 2017;5:134\u201342.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1100_CR6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/thy.2014.0300","volume":"25","author":"JS Yoon","year":"2015","unstructured":"Yoon JS, Lee HJ, Chae MK, Lee EJ. Autophagy is involved in the initiation and progression of Graves\u2019 orbitopathy. Thyroid. 2015;25:445\u201354.","journal-title":"Thyroid"},{"key":"1100_CR7","first-page":"339","volume":"33","author":"YQ Tian","year":"2008","unstructured":"Tian YQ, Ding P, Yan XH, Hu WJ. [Discussion on quality control of preparations with cortex moutan in volume\u00a0I pharmacopoeia of People\u2019s Republic of China (2005 edition)]. Zhongguo Zhong Yao Za Zhi. 2008;33:339\u201341.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1100_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0254-6272(13)60189-2","volume":"33","author":"S Ren","year":"2013","unstructured":"Ren S, Zhang H, Mu Y, Sun M, Liu P. Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med. 2013;33:413\u20136.","journal-title":"J Tradit Chin Med"},{"key":"1100_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1681.2008.05059.x","volume":"36","author":"JY Hu","year":"2009","unstructured":"Hu JY, Han J, Chu ZG, Song HP, Zhang DX, Zhang Q, et al. Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels. Clin Exp Pharmacol Physiol. 2009;36:351\u20137.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1100_CR10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1142\/S0192415X15500809","volume":"43","author":"XP Huang","year":"2015","unstructured":"Huang XP, Ding H, Lu JD, Tang YH, Deng BX, Deng CQ. Effects of the combination of the main active components of astragalus and panax notoginseng on inflammation and apoptosis of nerve cell after cerebral ischemia-reperfusion. Am J Chin Med. 2015;43:1419\u201338.","journal-title":"Am J Chin Med"},{"key":"1100_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12272-014-0336-2","volume":"37","author":"B Wang","year":"2014","unstructured":"Wang B, Chen MZ. Astragaloside IV possesses antiarthritic effect by preventing interleukin 1beta-induced joint inflammation and cartilage damage. Arch Pharm Res. 2014;37:793\u2013802.","journal-title":"Arch Pharm Res"},{"key":"1100_CR12","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.3892\/mmr.2016.4923","volume":"13","author":"H Xu","year":"2016","unstructured":"Xu H, Wang CY, Zhang HN, Lv CY, Wang YZ. Astragaloside IV suppresses inflammatory mediator production in synoviocytes and collageninduced arthritic rats. Mol Med Rep. 2016;13:3289\u201396.","journal-title":"Mol Med Rep"},{"key":"1100_CR13","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","volume":"111","author":"CR Chen","year":"2003","unstructured":"Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest. 2003;111:1897\u2013904.","journal-title":"J Clin Invest"},{"key":"1100_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb2757","volume":"15","author":"RC Russell","year":"2013","unstructured":"Russell RC, Tian Y, Yuan H, Park HW, Chang YY, Kim J, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. 2013;15:741\u201350.","journal-title":"Nat Cell Biol"},{"key":"1100_CR15","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1089\/ars.2010.3482","volume":"14","author":"I Tanida","year":"2011","unstructured":"Tanida I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal. 2011;14:2201\u201314.","journal-title":"Antioxid Redox Signal"},{"key":"1100_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77\u201388.","journal-title":"Methods Mol Biol"},{"key":"1100_CR17","doi-asserted-by":"crossref","first-page":"398483","DOI":"10.1155\/2015\/398483","volume":"2015","author":"P Lapaquette","year":"2015","unstructured":"Lapaquette P, Guzzo J, Bretillon L, Bringer MA. Cellular and molecular connections between autophagy and inflammation. Mediators Inflamm. 2015;2015:398483.","journal-title":"Mediators Inflamm"},{"key":"1100_CR18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.3273","volume":"16","author":"ST Shibutani","year":"2015","unstructured":"Shibutani ST, Saitoh T, Nowag H, Munz C, Yoshimori T. Autophagy and autophagy-related proteins in the immune system. Nat Immunol. 2015;16:1014\u201324.","journal-title":"Nat Immunol"},{"key":"1100_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00109-015-1297-8","volume":"93","author":"Z Yang","year":"2015","unstructured":"Yang Z, Goronzy JJ, Weyand CM. Autophagy in autoimmune disease. J Mol Med (Berl). 2015;93:707\u201317.","journal-title":"J Mol Med (Berl)"},{"key":"1100_CR20","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1038\/emm.2016.38","volume":"48","author":"JN Liu","year":"2016","unstructured":"Liu JN, Suh DH, Trinh HK, Chwae YJ, Park HS, Shin YS. The role of autophagy in allergic inflammation: a new target for severe asthma. Exp Mol Med. 2016;48:e243.","journal-title":"Exp Mol Med"},{"key":"1100_CR21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/thy.2015.0087","volume":"25","author":"L Marique","year":"2015","unstructured":"Marique L, Senou M, Craps J, Delaigle A, Van Regemorter E, Werion A, et al. Oxidative stress and upregulation of antioxidant proteins, including adiponectin, in extraocular muscular cells, orbital adipocytes, and thyrocytes in Graves\u2019 disease associated with orbitopathy. Thyroid. 2015;25:1033\u201342.","journal-title":"Thyroid"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-017-1100-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-017-1100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-017-1100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T04:00:05Z","timestamp":1515643205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-017-1100-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1007\/s00011-017-1100-0","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]}}}